Seres Therapeutics
MCRB • NASDAQ
Seres Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard N. Kender, with a market cap of $83.5M.
Market Cap$83.5M
Employees233.0
CEORichard N. Kender
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Seres Therapeutics FAQ
Common questions about Seres Therapeutics
Seres Therapeutics is scheduled to report earnings for Q1 2026 on May 6, 2026.
Seres Therapeutics has approximately 233 employees.